| Quarterly Financials | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 140 | 142 | 136 | 149 | 144 | 141 | 63 | 93 | 125 | 134 | 123 | 140 | 145 | 151 | 170 | 189 | 189 | 198 | 211 | 227 | 221 | 227 | 228 | 249 | 241 | 252 | 262 | 282 |
| Expenses | 122 | 122 | 121 | 130 | 127 | 126 | 72 | 85 | 108 | 109 | 109 | 119 | 126 | 132 | 148 | 164 | 162 | 170 | 182 | 191 | 186 | 187 | 187 | 199 | 195 | 204 | 214 | 224 |
| EBITDA | 18 | 19 | 15 | 18 | 17 | 15 | -8 | 9 | 17 | 25 | 14 | 21 | 19 | 18 | 22 | 25 | 27 | 28 | 29 | 37 | 34 | 40 | 41 | 50 | 46 | 48 | 48 | 58 |
| Operating Profit % | 12 % | 13 % | 11 % | 12 % | 12 % | 9 % | -14 % | 9 % | 13 % | 16 % | 11 % | 14 % | 12 % | 11 % | 11 % | 13 % | 14 % | 13 % | 13 % | 15 % | 15 % | 17 % | 16 % | 18 % | 16 % | 15 % | 16 % | 18 % |
| Depreciation | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 9 | 9 | 10 | 10 | 11 | 11 | 11 | 11 | 12 | 11 | 12 |
| Interest | 3 | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 7 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 7 | 7 |
| Profit Before Tax | 10 | 11 | 7 | 9 | 9 | 6 | -18 | -0 | 8 | 17 | 6 | 13 | 10 | 8 | 11 | 13 | 13 | 14 | 13 | 19 | 16 | 20 | 22 | 31 | 27 | 29 | 30 | 39 |
| Tax | 5 | 6 | 2 | 4 | 3 | 2 | -6 | -0 | 3 | 5 | 3 | 5 | 4 | -5 | 2 | 4 | 3 | 3 | 3 | 5 | 5 | 6 | 5 | 8 | 6 | 6 | 9 | 9 |
| Net Profit | 5 | 6 | 4 | 5 | 6 | 4 | -12 | 0 | 5 | 13 | 4 | 8 | 6 | 13 | 8 | 9 | 10 | 11 | 10 | 14 | 12 | 14 | 17 | 22 | 21 | 23 | 21 | 30 |
| EPS in ₹ | 3.71 | 4.21 | 3.26 | 4.18 | 4.25 | 3.26 | -8.83 | 0.11 | 4.03 | 9.59 | 2.93 | 0.62 | 0.49 | 1.00 | 0.64 | 0.68 | 0.78 | 0.79 | 0.72 | 1.00 | 0.85 | 1.04 | 1.14 | 1.42 | 1.32 | 1.47 | 1.35 | 1.90 |
Artemis Medicare Services
Artemis Medicare Services
285.46
-0.68
(-0.24%)
Market Cap
₹3,965.96 Cr
PE Ratio
47.21
Volume
1,37,508.00
Day High - Low
₹288.30 - ₹284.02
52W High-Low
₹350.00 - ₹207.71
Key Fundamentals
Market Cap
3,965.96 Cr
EPS
5.37
PB Ratio
3.91
Book Value
72.33
EBITDA
184.80
Dividend Yield
0.14 %
Industry
Healthcare Services Sector
Hospitals ROE Growth %
-
Debt to Equity
0.53
Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Artemis Medicare Reports 13.8% Revenue Growth in Q2FY26, Plans Major Expansion with New Facilities
Nov 18, 2025
Nov 18, 2025Artemis Medicare Services delivered consolidated revenue of INR 274.7 crores with 13.8% Y-o-Y growth and EBITDA margin of 21.2%, driven by strong performance in cardiac sciences, oncology, and international patients contributing 32% of revenues. The company is expanding aggressively with a 300-bed Raipur facility launching by March 2026, a 650-bed South Delhi hospital under binding MoU, and plans to increase Gurgaon capacity to 850-1,000 beds using additional FAR approvals.
IFC Converts Debentures Into 1.89 Crore Artemis Medicare Shares, Reduces Promoter StakeNov 17, 2025
International Finance Corporation was allotted 1,89,62,247 equity shares of Artemis Medicare Services Limited following conversion of 33,000 Compulsorily Convertible Debentures on November 15, 2025. The allotment increased the company's paid-up share capital from 13,92,38,250 to 15,82,00,497 equity shares, reducing promoter shareholding percentage from 66.38% to 58.43%.
Artemis Medicare Services Limited allotted 1,89,62,247 equity shares to International Finance Corporation (IFC) following the conversion of 33,000 compulsorily convertible debentures at Rs. 174.03 per share. The allotment increases the company's paid-up equity share capital from 13.92 crore to 15.82 crore shares, with the new shares to be listed and traded on BSE and NSE.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,162.80 | #1 1,13,051.65 | 83.67 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 54.18 | |
7,335.50 | 1,05,473.24 | 61.72 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 36.28 | |
919.10 | 69,388.20 | 68.04 | 7,849.70 | 13.25 | 809 | 70.27 | 33.39 | |
1,945.50 | 39,758.39 | 48.80 | 5,575.00 | 12.29 | 790 | 30.03 | 57.74 | |
665.45 | 34,478.36 | 94.45 | 4,286.70 | 15.12 | 337 | 14.65 | 45.83 | |
1,246.00 | 33,491.28 | 58.06 | 3,771.40 | 12.59 | 481 | 21.10 | 47.27 | |
685.10 | 27,413.52 | 75.73 | 3,067.00 | 21.98 | 415 | -40.35 | 46.53 | |
533.75 | 16,874.95 | 107.45 | 1,757.00 | 27.64 | 110 | 71.36 | 62.47 | |
5,986.90 | 15,278.08 | #1 28.77 | 599.90 | 11.69 | 58 | 16.17 | 35.67 | |
1,351.30 | 13,723.69 | 53.31 | 1,566.90 | 17.46 | 244 | -4.30 | 49.40 |
Growth Rate
Revenue Growth
9.48 %
Net Income Growth
67.41 %
Cash Flow Change
33.78 %
ROE
-9.90 %
ROCE
-3.55 %
EBITDA Margin (Avg.)
20.49 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
| Fixed Assets | 381 | 393 | 383 | 489 | 605 | 719 | 745 |
| Current Assets | 113 | 118 | 110 | 127 | 170 | 180 | 539 |
| Capital Work in Progress | 49 | 56 | 81 | 64 | 95 | 33 | 40 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 124 | 138 | 136 | 157 | 205 | 219 | 572 |
| Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
| Current Liabilities | 177 | 158 | 119 | 138 | 206 | 185 | 216 |
| Non Current Liabilities | 84 | 115 | 160 | 210 | 292 | 332 | 298 |
| Total Equity | 293 | 314 | 322 | 361 | 408 | 455 | 844 |
| Reserve & Surplus | 280 | 300 | 307 | 346 | 390 | 435 | 824 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 14 | 14 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 5 | 2 | 8 | -4 | 7 | -8 | 27 |
| Investing Activities | -50 | -26 | -37 | -107 | -158 | -88 | -385 |
| Operating Activities | 41 | 56 | 27 | 60 | 127 | 109 | 146 |
| Financing Activities | 14 | -27 | 18 | 44 | 38 | -29 | 267 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Nov 2025 |
| Promoter | 69.82 % | 69.82 % | 69.82 % | 69.82 % | 69.82 % | 69.59 % | 69.27 % | 68.92 % | 68.92 % | 68.03 % | 68.03 % | 68.03 % | 68.03 % | 67.51 % | 67.17 % | 67.17 % | 67.17 % | 66.53 % | 66.53 % | 58.43 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.09 % | 0.00 % | 0.10 % | 0.16 % | 0.22 % | 0.64 % | 0.31 % | 0.24 % | 0.37 % | 12.48 % |
| DIIs | 0.91 % | 0.91 % | 0.91 % | 0.91 % | 0.91 % | 0.91 % | 0.90 % | 1.15 % | 1.38 % | 1.41 % | 1.52 % | 1.20 % | 2.61 % | 3.45 % | 3.60 % | 4.50 % | 5.04 % | 4.76 % | 4.27 % | 3.35 % |
| Government | 7.36 % | 7.36 % | 7.36 % | 7.36 % | 7.36 % | 7.34 % | 7.31 % | 7.27 % | 7.27 % | 7.18 % | 7.18 % | 7.18 % | 7.18 % | 7.12 % | 7.09 % | 7.09 % | 7.09 % | 7.02 % | 7.02 % | 6.16 % |
| Public / Retail | 10.31 % | 14.18 % | 14.68 % | 15.21 % | 15.24 % | 16.82 % | 16.39 % | 16.33 % | 16.21 % | 15.51 % | 15.53 % | 15.20 % | 14.74 % | 14.23 % | 13.89 % | 12.76 % | 12.86 % | 12.93 % | 13.44 % | 11.65 % |
| Others | 11.59 % | 7.72 % | 7.22 % | 6.69 % | 6.66 % | 5.35 % | 6.13 % | 6.32 % | 6.23 % | 7.87 % | 7.65 % | 8.39 % | 7.34 % | 7.53 % | 8.03 % | 7.84 % | 7.53 % | 8.52 % | 8.37 % | 7.93 % |
| No of Share Holders | 0 | 5,273 | 6,010 | 10,765 | 12,827 | 12,098 | 15,177 | 14,637 | 18,100 | 19,082 | 20,529 | 22,375 | 19,993 | 19,795 | 26,054 | 27,003 | 28,397 | 31,614 | 33,559 | 31,884 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.45 | 0.45 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.16 | 0.16 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Jul 2023 |  Dividend | ₹ 0.45 /share | 14 Jul 2023 | 77.03 | 121.20 |
| 03 May 2024 |  Extraordinary General Meeting | NA | 03 May 2024 | 187.65 | 183.75 |
| 05 Jul 2024 | Dividend | ₹ 0.45 /share | 05 Jul 2024 | 193.20 | 183.88 |
| 24 Jul 2024 |  Annual General Meeting | NA | 24 Jul 2024 | 180.15 | 223.24 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 274.55 | 269.50 |
| 05 Feb 2025 | Quarterly Result Announcement | NA | 05 Feb 2025 | 308.55 | 317.60 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 261.55 | 240.05 |
| 11 Jul 2025 | Dividend | ₹ 0.45 /share | 11 Jul 2025 | 240.05 | 252.25 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 244.30 | 234.60 |
| 05 Aug 2025 | Quarterly Result Announcement | NA | 05 Aug 2025 | 234.60 | 249.15 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 244.95 | 245.00 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 18, 2025
Nov 18, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 17, 2025
Nov 17, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesNov 15, 2025
Nov 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Nov 11, 2025Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter/ Half Year Ended September 30 2025
Nov 11, 2025
Nov 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On November 11 2025Nov 11, 2025
Nov 11, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Nov 05, 2025Board Meeting Intimation for Consideration Of Un-Audited Financial ResultsNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 17, 2025
Oct 17, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowOct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 17, 2025
Sep 17, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowSep 11, 2025
Sep 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 04, 2025
Sep 04, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 05, 2025
Aug 05, 2025Unaudited Financial Result (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2025Aug 05, 2025
Aug 05, 2025Board Meeting Outcome for Board Meeting Held On August 5 2025Aug 05, 2025
Aug 05, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 01, 2025
Aug 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2025
Jul 31, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Jul 30, 2025Board Meeting Intimation for Consideration Of Un-Audited Financial ResultsJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2025
Jul 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 08, 2025
Jul 08, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 07, 2025
Jul 07, 2025Reg. 34 (1) Annual Report.Jul 07, 2025
Jul 07, 202521St Annual General Meeting To Be Held On Wednesday July 30 2025 At 3:00 P.M. (IST)
Jul 07, 2025
Jul 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 01, 2025
Jul 01, 2025Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Record Date For Payment Of Final DividendJun 20, 2025
Jun 20, 2025Intimation Of Annual General MeetingJun 20, 2025
Jun 20, 2025Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 17, 2025
Jun 17, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan Small Cap Fund Direct-Growth | 0.09% | 43048 | 0.01% | 0.00% | |
 LIC MF Children's Fund Direct-Growth | 0.81% | 2338 | 0.38% | 0.41% | |
| LIC MF Focused Fund Direct - Growth | 3.36% | 475 | 0.04% | 0.33% | |
| LIC MF Value Fund Direct - Growth | 1.50% | -31 | -0.03% | -0.25% | |
| Bandhan BSE Healthcare Index Fund Direct-Growth | 0.05% | 2 | 0.00% | 0.00% | |
| Bandhan Midcap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 HSBC Focused Fund Direct - Growth | 1.81% | 0 | 0.04% | 0.15% | |
| LIC MF Healthcare Fund Direct - Growth | 3.08% | 0 | 0.08% | 0.38% | |
| LIC MF Small Cap Fund Direct - Growth | 1.55% | 0 | 0.05% | 0.37% | |
 TRUSTMF Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 70.27
ATR(14)
Less Volatile 9.39
STOCH(9,6)
Neutral 65.64
STOCH RSI(14)
Neutral 69.96
MACD(12,26)
Bullish 1.53
ADX(14)
Strong Trend 43.45
UO(9)
Bearish 55.17
ROC(12)
Uptrend And Accelerating 13.57
WillR(14)
Neutral -20.73
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
